Amid a structural shift towards Asia, Insilico Medicine's IPO in December was a significant moment for the exchange, while French biotech TheraVectys is understood to be considering a listing.
CEO Darren Wang described the process to FA as “difficult” and said that reaching out to more US-based private investors, while expanding globally, is the next step.
Hong Kong stocks and listings have performed well since the start of the year as depressed valuations and budding confidence has shifted capital away from US stocks; more listings this week show the momentum is here to stay, despite tariff uncertainty.
FA understands the bank is making a number of senior leadership changes and hires across ECM, investment banking and technology, in Hong Kong, Singapore, Sydney and San Francisco; including Apac Equity Syndicate leader and head of SEA ECM.